Established in 2015, Aziyo Biologics is a privately-held, commercially-oriented biotech company focused on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties

Since its founding, the Company has expanded through a combination of acquisitions and strategic partnerships, creating a high-growth commercial entity. Our mission is to restore health and mobility through the development of innovative new solutions that expand the possibilities of regenerative medicine.

  • Proxicor for Intracardiac Repair

    ProxiCor for Cardiac Tissue Repair is intended for use as an intracardiac patch or pledget for tissue repair (i.e. atrial septal defect [ASD], ventricular septal defect [VSD], etc.) and suture-line buttressing.

    See Product
  • Proxicor for Pericardial Closure

    ProxiCor for Pericardial Closure is used to restore the pericardium by providing a natural bio-scaffold that allows the patient’s own cells to form a new pericardial layer.

    See Product
  • CanGaroo

    The CanGaroo Envelope is made up of a naturally occurring bio-scaffold that is intended to securely hold both cardiac implantable electronic devices (CIEDs) such as pacemakers and defibrillators and neurostimulators including vagus nerve, deep brain and sacral nerve stimulators as well as spinal cord neuromodulators when implanted in the body.

    See Product